Atlas Trials

Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge

Clinical trial NCT05418049 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05418049
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Fragile X Syndrome
Start date
2022-09-08
Primary completion
2025-10-28
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.